| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 588.11B | 588.83B | 562.28B | 509.07B | 419.19B | 364.62B |
| Gross Profit | 185.40B | 175.74B | 164.77B | 129.78B | 118.14B | 113.53B |
| EBITDA | 75.65B | 77.89B | 73.74B | 51.33B | 47.58B | 48.64B |
| Net Income | 34.91B | 38.31B | 67.11B | 25.20B | 26.53B | 20.03B |
Balance Sheet | ||||||
| Total Assets | 744.94B | 750.70B | 689.70B | 671.95B | 600.06B | 606.58B |
| Cash, Cash Equivalents and Short-Term Investments | 102.19B | 109.14B | 100.80B | 95.14B | 68.28B | 124.45B |
| Total Debt | 213.42B | 218.42B | 122.56B | 126.22B | 73.67B | 122.92B |
| Total Liabilities | 409.46B | 400.69B | 309.45B | 318.93B | 224.94B | 267.72B |
| Stockholders Equity | 260.45B | 269.41B | 309.96B | 292.91B | 320.02B | 286.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 14.86B | 51.12B | 40.88B | 955.00M | 32.05B |
| Operating Cash Flow | 0.00 | 34.97B | 67.08B | 50.23B | 15.52B | 42.65B |
| Investing Cash Flow | 0.00 | -34.89B | -9.04B | -10.47B | -2.09B | -342.00M |
| Financing Cash Flow | 0.00 | -12.32B | -72.86B | -18.47B | -64.10B | 16.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥774.63B | 17.03 | 12.15% | 1.58% | 2.62% | 2.81% | |
74 Outperform | ¥161.04B | 8.76 | 6.23% | 1.11% | 2.88% | 16.60% | |
74 Outperform | ¥36.04B | 15.61 | ― | 3.70% | 14.83% | 51.42% | |
69 Neutral | ¥2.33T | 13.66 | 11.64% | 1.52% | 9.81% | 32.64% | |
68 Neutral | ¥415.99B | 7.90 | 13.71% | 3.38% | 0.29% | 27.84% | |
65 Neutral | ¥349.18B | 10.69 | 8.14% | 2.61% | -1.45% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |